ASP Drug Pricing - (3rd Quarter)
July 2023
Payment Allowance Limits for Medicare Part B Drugs

  • Note 1: Payment allowance limits subject to the ASP methodology are based on Jan 2023 (1st Quarter) ASP data.
  • Note 2: The absence or presence of a HCPCS code and the payment allowance limits in this table does not indicate Medicare coverage of the drug. Similarly, the inclusion of a payment allowance limit within a specific column does not indicate Medicare coverage of the drug in that specific category. These determinations shall be made by the local Medicare contractor processing the claim.
 
Page 10 * Effective Jul 1, 2023 through Sep 30, 2023
HCPCS Code Code Dosage Payment
Limit		 Vaccine AWP % Vaccine Limit Infusion AWP % DME infusion limit Blood AWP % Blood limit Clotting factor Note
J1746 - Injection, ibalizumab-uiyk, 10 mg 10 MG 74.292 19.82% - - - - -
J1747 - Injection, spesolimab-sbzo, 1 mg 1 MG 60.223 20% - - - - -
J1750 - Injection, iron dextran, 50 mg 50 MG 17.176 20% - - - - -
J1756 - Injection, iron sucrose, 1 mg 1 MG 0.206 20% - - - - -
J1786 - Injection, imiglucerase, 10 units 10 UNITS 44.25 20% - - - - -
J1805 - Injection, esmolol hydrochloride, 10 mg 10 MG 0.25 20% - - - - -
J1806 - Injection, esmolol hydrochloride (wg critical care), not therapeutically equivalent to j1805, 10 mg 10 MG 0.486 20% - - - - -
J1811 - Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units 50 UNITS 7.195 20% - - - - -
J1813 - Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units 50 UNITS 15.73 20% - - - - -
J1817 - Insulin for administration through dme (i.e., insulin pump) per 50 units 50 UNITS 8.395 20% - - - - -
J1823 - Injection, inebilizumab-cdon, 1 mg 1 MG 472.303 20% - - - - -
J1836 - Injection, metronidazole, 10 mg 10 MG 0.024 20% - - - - -
J1885 - Injection, ketorolac tromethamine, per 15 mg 15 MG 0.546 20% - - - - -
J1920 - Injection, labetalol hydrochloride, 5 mg 5 MG 0.244 20% - - - - -
J1921 - Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg 5 MG 1.237 20% - - - - -
J1930 - Injection, lanreotide, 1 mg 1 MG 54.182 20% - - - - -
J1931 - Injection, laronidase, 0.1 mg 0.1 MG 37.043 20% - - - - -
J1932 - Injection, lanreotide, (cipla), 1 mg 1 MG 51.378 20% - - - - -
J1940 - Injection, furosemide, up to 20 mg 20 MG 0.495 20% - - - - -
J1943 - Injection, aripiprazole lauroxil, (aristada initio), 1 mg 1 MG 3.06 20% - - - - -
J1944 - Injection, aripiprazole lauroxil, (aristada), 1 mg 1 MG 3.067 20% - - - - -
J1950 - Injection, leuprolide acetate (for depot suspension), per 3.75 mg 3.75 MG 1543.516 19.376% - - - - -
J1951 - Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg 0.25 MG 138.807 20% - - - - -
J1952 - Leuprolide injectable, camcevi, 1 mg 1 mg 78.308 20% - - - - -
J1953 - Injection, levetiracetam, 10 mg 10 MG 0.073 20% - - - - -
* Effective Jul 1, 2023 through Sep 30, 2023

Drugs not otherwise classified - July 2023

 

Medicare Part B payment allowance limits for drugs not otherwise classified - Effective Jul 1, 2023 through Sep 30, 2023

Drug name Dosage Payment limit Notes
Aminocaproic acid 250 MG 0.305
Aztreonam 500 MG 14.775
Bumetanide 0.25 MG 0.383
Carmustine (Accord) 100 MG 654.42
Diltiazem Hydrochloride 5 MG 0.342
Doxycycline Hyclate 100 MG 16.063
Famotidine 10 MG 0.417
Flumazenil 0.1 MG 0.812
Folic Acid 5 MG 2.586
Furosemide (Phlow Corporation) 20 MG 1.579
Glucarpidase 10 UNITS 380.699
Glycopyrrolate injection 0.2 MG 1.348 providers must check the crosswalk file to determine the correct payment allowance
Glycopyrrolate injection (Fresenius Kabi) 0.2 MG 4.852 providers must check the crosswalk file to determine the correct payment allowance
Metoprolol Tartrate 1 MG 0.151
Olanzapine short acting intramuscular injection 0.5 MG 0.9
Rifampin 600 MG 111.851
Sodium Chloride, Hypertonic (3% - 5% infusion) 250 CC 1.763
Sulfamethoxazole-Trimethoprim 400-80 MG 0.892

ASP (Average Sale Price) Drug Pricing History